Form 4 for ATRA Atara Biotherapeutics, Inc.
Accepted 2023-02-09 00:00:00 ET · period of report 2023-02-07 · accession 0001567619-23-002174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-09 | 2023-02-07 | ATRA | Koppikar Utpal | CFO | S - Sale | $5.46 | -2,485 | 188.8K | -1% | -$13.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-07 | S | D | 2,485 | $5.46 | 188,849 | D | — | — |